CEL.L - Celadon Pharmaceuticals Plc Stock Price & Dividend Safety Sector: Healthcare | Exchange: London Stock Exchange Current Price & Safety Score Price: 13.40 GBp StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): -6.29 StockBond Score: -2.36 Company Description Celadon Pharmaceuticals Plc a pharmaceutical company engages in the research manufacture and supply of cannabinoids for use in approved medicines The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain It also intends to conduct research into cannabinoids for use in chronic pain as well as other conditions such as autism and multiple sclerosis The company was founded in 2018 and is headquartered in London the United Kingdom